Clinical Studies
Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
NeuroOphthalmology
Obesity/Weight Management
Women's Health
Other
Special Features
Advances/Research
Nonablative fractional laser resurfacing for acne scarring in patients with Fitzpatrick skin phototypes IV-VI
| Principal Investigator: | Andrew F. Alexis, MD, MPH | |
| Co-principal Investigator: | Marcelyn Coley, MD | |
| Time frame of study: | January 2010- June 2010 | |
| Time frame of participation: | 5 months | |
| Number of participants needed: | 15 | |
| Clinical Area this Study Falls Under | Dermatology | |
| Location of Study: | St. Luke's-Roosevelt Hospital Center | |
| Contact name, number and email | Clinical Research Office (212) 523-4511 |
Summary:
We are inviting the community to take part in a prospective, split-face, randomized controlled study assessing efficacy and safety of nonablative fractional resurfacing laser treatments for facial acne scarring in patients of color, (skin types IV-VI). The patient will undergo a series of four (4) laser treatments to selected symmetrical affected areas of the face at 4-week intervals. Photographs, surveys, as well as investigator and patient scar assessments will be performed at each visit for a total of 6 visits.
Criteria
for Participation:
18 years or older
Desires correctio of acne scarring on face
Patients of color (Fitzpatrick skin types IV-VI)
No laser treatments on face in past 6 months
No discoloration disorders on the face (e.g. vitiligo, melasma)
Benefits and/or Compensation:
Evaluation and treatment by a board-certied dermatologist
FDA approved laser-assisted correction of facial acne scarring at no cost for the procedure